Top Markets
Coin of the day
Allergy Therapeutics plc Allergy Therapeutics plc

Allergy Therapeutics plc

AGY
Peringkat dalam Saham #35053
Allergy Therapeutics plc is a biotechnology firm dedicated to the research and... Allergy Therapeutics plc is a biotechnology firm dedicated to the research and development of innovative treatments for allergies. The company offers a range of injectable and sublingual immunotherapies specifically targeting allergens, alongside diagnostic tools and prescription solutions for pollen-related allergies, including those caused by grasses, weeds, and trees. Its diverse product portfolio features Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. Furthermore, Allergy Therapeutics is actively advancing new vaccine candidates designed to address sensitivities to trees, grass, house dust mites, animal dander, and peanuts. With operations spanning Central Europe, Southern Europe, the United Kingdom, and various other international markets, Allergy Therapeutics plc was established in 2004 and is headquartered in Worthing, UK.
Harga Saham
$0.07143683
Terakhir disinkronkan: 2026-08-14
Kapitalisasi Pasar
$4.52M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-37.27%
Negara
GB
Perdagangan Allergy Therapeutics plc (AGY)

Kategori

Rasio P/B untuk Allergy Therapeutics plc (AGY)
Rasio P/B per 2026 TTM: 0
Menurut laporan keuangan dan harga saham terbaru dari Allergy Therapeutics plc, rasio P/B saat ini (TTM) adalah 0. Pada akhir 2026, rasio P/B perusahaan adalah 0.
Riwayat rasio P/B untuk Allergy Therapeutics plc dari 2026 hingga 2026
Rasio P/B pada akhir setiap tahun
Tahun Rasio P/B Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Rasio P/B untuk perusahaan sejenis atau pesaing